glp-1 agonists vs bariatric surgery weight loss comparison vs. Medication: What's Better? GLP-1 vs. Bariatric Surgery: 1-

Additional class-related concerns include: Gallbladder disease , including cholelithiasis (gallstones) and cholecystitis, as observed with GLP-1 receptor agonist medicines [27] Dehydration and acute kidney injury (AKI) risk secondary to significant gastrointestinal fluid losses Increased heart rate , a recognised class effect of GLP-1 receptor agonists Pancreatitis a potential risk that warrants prompt medical assessment if severe abdominal pain develops Thyroid C-cell tumours observed in rodent studies with GLP-1 receptor agonists

Mechanism of Action: Dihexa binds with high affinity to hepatocyte growth factor (HGF), activating c-Met receptors, which leads to increased synaptic connectivity and neurogenesis

This extended signaling allows for a steady, basal increase in growth hormone and IGF-1 levels without causing the aggressive spikes that disrupt natural endocrine rhythms

Collectively, disease modeling with SC-islets further confirmed that zinc accumulation induces loss of -cell identity

Research Documentation Context Supports compound characterization in controlled laboratory settings